Here are relevant reports on : in-vitro-diagnostics-market
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cancer Diagnostics Market by Product (Consumables (Antibodies, Probes), Instruments), Technology (IVD Testing, Anatomic pathology, Imaging, Biopsy), Type (Tumors, Breast, Lung Cancer), Application, End User (Hospitals) & Region – Global Forecast to 2031
The global cancer diagnostics market is projected to reach USD 44.92 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030
The global liquid handling systems market, valued at US$4.75B in 2024, is forecasted to grow at a 8.0% CAGR, reaching US$ 5.10B by 2025 and US$7.48B by 2030. The increasing trend of outsourcing pharmaceutical research enables businesses to cut costs and obtain specialty expertise. Rising investments in life sciences research and development are helping fuel innovation across the drug discovery and development process.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Imaging Chemicals Market by Product Type (Printing Inks, Image Developers), Application (Printing & Packaging, Medical Diagnostics, Textile Processing), and Region (North America, Europe, APAC, MEA, and South America) - Global Forecast to 2022
The imaging chemicals market is estimated to grow from USD 22.08 Billion in 2017 to USD 29.97 Billion by 2022, at a CAGR of 6.3% from 2017 to 2022. Imaging chemicals are chemicals substances that used to produce or develop photographs. The imaging chemicals market is segmented by product type, application, and region. Key companies profiled in this research report on the imaging chemicals market include Fujifilm (Japan), The Eastman Kodak Company (US), Vivimed Labs (India), DIC Corp. (Japan), Flint Group (Germany), Sakata Inx (Japan), Toyo Ink SC (Japan), Siegwerk Druckfarben (Germany), and T&K Toka (Japan).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Construction & Mining Fleet Management Market by Solution (Operations Management, Battery Maintenance & Diagnostics, Performance Management, Fleet Analytics & Reporting), Fleet Type (Passenger Cabs, Commercial, Public Transport) - Global Forecast to 2030
The construction & mining fleet management market is projected to reach USD 7.28 billion by 2030, growing from USD 4.04 billion in 2025 at a CAGR of 12.5% during the forecast period. The key players include Caterpillar (US), Komatsu (Japan), Volvo (Sweden), Samsara (US), Wenco (Canada), Hexagon (Sweden), Sandvik (Sweden), RPMGlobal (Australia), Verizon Connect (US), Teletrac Navman (US), JCB (UK), Liebherr (Switzerland), CNH Industrial America (US), Geotab (Canada), and Epiroc (Sweden).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
AI in Telecommunication Market by Technology, Application (Network Optimization, Network Security, Self-diagnostics, Customer Analytics, and Virtual Assistance), Component (Solutions and Services), Deployment Mode, and Region - Global Forecast to 2022
The increasing adoption of Artificial Intelligence (AI) for various applications in the telecommunication industry and utilization of AI-enabled smartphones are expected to be driving the growth of the AI in telecommunication market. MarketsandMarkets expects the global AI in telecommunication market to grow from USD 235.7 Million in 2016 to USD 2,497.8 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 46.8% during the forecast period. The base year considered for the study is 2016 and the forecast period is 2017–2022. The AI in telecommunication market report encompasses the competitive landscape and company profiles of the key vendors based on their product offerings and business strategies. The major AI in telecommunication vendors include IBM (US), Microsoft (US), Intel (US), Google (US), AT&T (US), Cisco Systems (US), Nuance Communications (US), Sentient Technologies (US), H2O.ai (US), Infosys (India), Salesforce (US), and NVIDIA (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
